FEATURES OF THE CLINICAL COURSE OF ARTERIAL HYPERTENSION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
18.10.2022
International Scientific Journal "Science and Innovation". Series D. Volume 1 Issue 7
S.Ellamonov , E.Tashkenbaeva , G.Abdieva
Abstract. Diabetes mellitus and hypertension are among the most common diseases worldwide, and their frequency increases with age. Elevated blood pressure (BP) values are common in patients with type 2 diabetes mellitus (DM2) and reflect, at least in part, the impact of underlying insulin resistance on the vasculature and kidneys. On the contrary, accumulating evidence suggests that carbohydrate metabolism disorders are more common in hypertensive patients, thus indicating that the pathogenic relationship between diabetes mellitus and hypertension is in fact bidirectional.
The development of hypertension in diabetics not only complicates the treatment strategy and increases healthcare costs, but also significantly increases the risk of macrovascular and microvascular complications. Although the reduction in blood pressure is followed by a significant reduction in cardiovascular and microvascular morbidity and mortality, a significant proportion of patients with diabetes mellitus exhibit poorly controlled hypertension. This observation may reflect not only delayed recognition of the presence of hypertension, clinical inertia, and poor adherence, but also uncertainty about treatment goals and pathogen correlation.
Keywords: arterial hypertension, diabetes mellitus, uncontrolled hypertension, risk factors, complications.
References:
1. Абдиева Г. А., Ташкенбаева Э. Н. ВЛИЯНИЕ МЕТАБОЛИЧЕСКИХ И СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ НА ТЕЧЕНИЕ COVID-19 //Журнал кардиореспираторных исследований. – 2022. – Т. 3. – №. 2.
2. Расули Ф. О. и др. ОСОБЕННОСТИ РАЗВИТИЯ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ У БОЛЬНЫХ С ИБС НА ФОНЕ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ //Журнал кардиореспираторных исследований. – 2020. – Т. 1. – №. 3.
3. ТАШКЕНБАЕВА Э. Н. и др. РОЛЬ РЕГУЛЯТОРНЫХ ЦИТОКИНОВ В ФОРМИРОВАНИИ И ПРОГРЕССИРОВАНИИ ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦА АССОЦИИРОВАННОЙ БЕССИМПТОМНОЙ ГИПЕРУРИКЕМИЕЙ.
4. Fatulloyeva D. S. et al. Evaluation of the effectiveness of thrombolytic therapy in myocardial infarction in the conditions of the samarkand branch of rscemc //Euro-Asia Conferences. – 2021. – Т. 1. – №. 1. – С. 177-182.
5. Rasuli F. O. et al. Clinical features of ihd course on the background of atrial fibrillation //Euro-Asia Conferences. – 2021. – Т. 1. – №. 1. – С. 195-199.
6. V. Tsimihodimos, C. Gonzalez-Villalpando, J.B. Meigs, E. Ferrannini, Hypertension and diabetes mellitus:coprediction and time trajectories, Hypertension 71 (3) (2018) 422–428
7. Istamova S. S. et al. LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION IN COMORBID CONDITION //Euro-Asia Conferences. – 2021. – Т. 1. – №. 1. – С. 334-338.
8. Istamova S. S. et al. FEATURES OF THE CLINICAL COURSE OF HEART FAILURE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION IN THE BACKGROUND OF TYPE 2 DIABETES MELLITUS //E-Conference Globe. – 2021. – С. 1-3.
9. Абдиева Г., Ташкенбаева Э., Музаффарова Ю. Факторы риска развития сердечно-сосудистых заболеваний у женщин в климактерическом периоде //Журнал проблемы биологии и медицины. – 2016. – №. 4 (91). – С. 156-158.
10. WHO. Obesity, Preventing and Managing the Global Epidemic. Report of a WHO Consultation, in: 4, World Health Organization, Geneva, 2000. WHO Technical Report Series 89.
11. Tashkenbaeva E. N., Abdieva G. A. FEATURES OF ISCHEMIC HEART DISEASE IN ASSOCIATION WITH CLIMACTERIC CARDIOPATHY //European Science Review. – 2018. – №. 3-4. – С. 190-192.
12. Элламонов С. Н. и др. Факторы прогрессирования артериальной гипертензии у больных в коморбидности с сахарным диабетом 2 типа //Журнал кардиореспираторных исследований. – 2021. – Т. 2. – №. 2.
13. Ташкенбаева Э. и др. РАСПРОСТРАНЕННОСТЬ МЕТАБОЛИЧЕСКОГО СИНДРОМА У ПАЦИЕНТОВ С ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА //Журнал кардиореспираторных исследований. – 2021. – Т. 2. – №. 1. – С. 85-88.
14. Байта С. К., Ташкенбаева Э. Н., Абдиева Г. А. Effects of smoking on cardiovascular function: the role of nicotine and carbon monoxide //Журнал кардиореспираторных исследований. – 2021. – Т. 2. – №. 2.
15. Tashkenbaeva E. N., Abdieva G. A. FEATURES OF ISCHEMIC HEART DISEASE IN ASSOCIATION WITH CLIMACTERIC CARDIOPATHY //European Science Review. – 2018. – №. 3-4. – С. 190-192.
SCIENCE & INNOVATION